Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2059]

Programming cells to target brain tumours

Programming cells to target brain tumours

Antidepressant shows promise for treating brain tumours

Antidepressant shows promise for treating brain tumours

Tailoring radiation therapy for brain cancer treatment: a personal investigation

Tailoring radiation therapy for brain cancer treatment: a personal investigation

ESMO 2024: Combination therapy reduced agitated delirium in patients with advanced cancers

ESMO 2024: Combination therapy reduced agitated delirium in patients with advanced cancers

ESMO 2024: Trastuzumab deruxtecan effective against brain mets in HER2-positive breast cancer

ESMO 2024: Trastuzumab deruxtecan effective against brain mets in HER2-positive breast cancer

Next-gen vaccines offer new hope against glioblastoma

Next-gen vaccines offer new hope against glioblastoma

How the scars of demolished brain tumours seed relapse

How the scars of demolished brain tumours seed relapse

WCLC 2024: Ivonescimab outperforms pembrolizumab in phase 3 study for first-line treatment of PD-L1-positive advanced NSCLC in HARMONi-2 study

WCLC 2024: Ivonescimab outperforms pembrolizumab in phase 3 study for first-line treatment of PD-L1-positive...

New study uncovers key mechanisms responsible for the transformation of adult progenitors into brain tumours

New study uncovers key mechanisms responsible for the transformation of adult progenitors into brain tumours

Scientists working to understand why men with prostate cancer are at higher risk of Alzheimer’s

Scientists working to understand why men with prostate cancer are at higher risk of Alzheimer’s

More from ecancer